22.4 Common Traps in Ophthalmic Imaging
Key Takeaways
- Do not confuse fluorescein (retinal vessels, visible light, no iodine) with ICG (choroidal vessels, near-infrared, contains iodine).
- Yellow skin and urine are expected fluorescein effects, not adverse reactions; nausea is the most common true reaction.
- OCT does not need dilation or dye; FA needs both dilation and an IV dye plus consent and allergy screening.
- A familiar-sounding device name is not the answer unless it images the bed the clinical question is asking about.
22.4 Common Traps in Ophthalmic Imaging
Imaging distractors are predictable once you know the swaps the test writers favor. Learn the trap, and the wrong answers light up.
Trap 1: fluorescein vs. ICG confusion
The two dye studies are constantly swapped in distractors. Lock in the contrasts:
| Feature | Sodium fluorescein (FA) | Indocyanine green (ICG) |
|---|---|---|
| Vascular bed | Retinal vessels | Choroidal vessels |
| Light/fluorescence | Visible (blue excitation) | Near-infrared |
| Iodine content | No | Yes (screen allergy/liver) |
| Best for | Diabetic retinopathy, vein occlusion, leakage | Choroidal neovascularization, central serous |
| Dose | 500 mg IV | About 25 mg IV in sterile water |
If a stem mentions a choroidal process or near-infrared imaging, the answer is ICG, not fluorescein, even though fluorescein is the more familiar word.
Trap 2: expected effect vs. true adverse reaction
The exam will offer 'yellow skin' or 'yellow urine' as if it were a complication. It is not. These are expected results of renal and dermal dye clearance. The true reactions, in rising severity, are nausea (most common), vomiting, urticaria/itching, and rarely bronchospasm or anaphylaxis. Pick the reassurance answer for expected effects and the escalate-and-summon-clinician answer for true hypersensitivity.
Trap 3: assuming every study needs dilation and dye
- OCT: no dye, usually no dilation, non-contact.
- Non-mydriatic fundus camera: no dilation by design.
- Standard fundus / FA / ICG: dilation improves or is required for the field.
- Only FA and ICG inject an IV dye and therefore need consent and allergy screening.
An answer that says 'fast the patient overnight' or 'discontinue the study because urine turned yellow' is almost always a trap.
Trap 4: matching the modality to the wrong layer
Work the checklist before you commit to an answer:
- What tissue or vessel bed is the clinical question about? (surface, layers, retinal vessels, choroidal vessels)
- Does the requested study actually image that bed?
- Is there a dye-safety cue (allergy, iodine, pregnancy, liver disease)?
- Is the captured image diagnostic, or must it be recaptured?
- Is the patient and eye correctly verified and the file correctly labeled?
Choose the answer that images the right bed, is safest for the patient, and yields a usable, correctly attached image. A device that sounds advanced but cannot show the requested structure is still wrong.
Trap 5: confusing OCT and OCT angiography
Newer questions distinguish standard OCT (structural cross-section and thickness maps) from OCT angiography (OCTA), a dye-free technique that detects blood flow by motion contrast between repeated scans. The trap is assuming any flow study needs dye. OCTA shows retinal and choroidal capillary networks without any injection, while FA and ICG require IV dye. If a stem emphasizes 'no dye but show me the flow,' OCTA is the answer; if it emphasizes leakage over time, FA is still the answer because OCTA shows flow, not leakage.
Trap 6: dose and concentration mix-ups
The fluorescein dose is a favorite distractor. The standard adult dose is 500 mg IV, supplied as 5 mL of a 10% solution or 2 mL of a 25% solution, both of which deliver the same 500 mg. Answer choices may offer the same milligram dose at a wrong volume, or a different milligram dose entirely. Anchor on the 500 mg figure and the two equivalent volume/concentration pairs.
Trap 7: treating documentation as optional
Under time pressure, an answer that skips recording the dye dose, lot, time, or any reaction can look efficient. It is a trap. For any injectable, the chart must capture agent, dose, lot, route, time, and reaction, and images must be filed to the right patient and eye. The most defensible answer protects the audit trail.
Work the trap-detection checklist before committing: (1) which bed is the question about; (2) does the chosen study image that bed; (3) is there a dye-safety screen (iodine, allergy, pregnancy, liver); (4) is the image diagnostic or does it need recapture; (5) is the patient, eye, and file correctly verified. The answer that survives all five is the right one.
Trap 8: the impressive-but-wrong device
Test writers exploit recognition bias by placing the most advanced-sounding modality in the answer list even when it cannot show the requested structure. Ultra-widefield imaging, OCT angiography, and ICG all sound sophisticated, but if the clinical question is simply 'document the color appearance of the disc and vessels,' the correct answer is plain fundus photography. Conversely, if the question demands choroidal flow, no amount of OCT structural detail substitutes for ICG. The fix is to ignore how advanced an option sounds and ask only whether it images the bed the stem is asking about.
The same discipline defeats distractors that pair a real modality with a false capability, such as claiming fundus photography measures retinal thickness (that is OCT) or that OCT shows dye leakage over time (that is FA). Read each option as a claim about a bed and a capability, and reject any option where either half is wrong. This single habit neutralizes most imaging traps, because the test relies on candidates matching a familiar word rather than checking that the device actually answers the clinical question being asked in the stem.
Which pairing of dye property is INCORRECT and therefore a common exam trap?